Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
May 31, 2007

Medarex and Mitsubishi Join Forces to Target Autoimmune Diseases

  • Medarex is partnering with Mitsubishi Pharma to generate and evaluate fully human mAbs against a Mitsubishi target for the treatment of autoimmune diseases.

    The companies will use Medarex' UltiMAb Human Antibody Development System® to generate antibodies. The companies will share research responsibilities for any antibodies found through the collaboration.



Be sure to take the GEN Poll

CRISPR Patent Controversy

Do you think recently released email from a former Broad Institute scientist to Jennifer Doudna will expedite a final legal decision on who owns the CRISPR patent?

More »